Adynovate recombinant and Tofacitinib Citrate
Determining the interaction of Adynovate recombinant and Tofacitinib Citrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Adynovate (recombinant)
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adynovate recombinant-Tofacitinib Extended-Release Tablets
- Adynovate recombinant-Tofacitinib Tablets
- Adynovate recombinant-Tofranil
- Adynovate recombinant-Tofranil injection
- Adynovate recombinant-Tofranil-PM
- Adynovate recombinant-Tol-Tab
- Tofacitinib Citrate-Adzenys ER
- Tofacitinib Citrate-Adzenys ER Oral Suspension
- Tofacitinib Citrate-Adzenys XR-ODT
- Tofacitinib Citrate-Aemcolo
- Tofacitinib Citrate-Aerobid
- Tofacitinib Citrate-Aerobid-M